| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 2010 | 2018 |
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal … A Hendlisz, MV Eynde, M Peeters, G Maleux, B Lambert, J Vannoote, ... Journal of clinical oncology 28 (23), 3687-3694, 2010 | 514 | 2010 |
| Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised … C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ... The lancet oncology 20 (6), 849-861, 2019 | 508 | 2019 |
| Evolution of metastases in space and time under immune selection M Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ... Cell 175 (3), 751-765. e16, 2018 | 413 | 2018 |
| Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised … CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ... The Lancet Oncology 20 (3), 420-435, 2019 | 275 | 2019 |
| The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ... Cancer cell 34 (6), 1012-1026. e3, 2018 | 261 | 2018 |
| Comprehensive intrametastatic immune quantification and major impact of immunoscore on survival B Mlecnik, M Van den Eynde, G Bindea, SE Church, A Vasaturo, ... JNCI: Journal of the National Cancer Institute 110 (1), 97-108, 2018 | 259 | 2018 |
| Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres R Lhommel, L Van Elmbt, P Goffette, M Van den Eynde, F Jamar, ... European journal of nuclear medicine and molecular imaging 37, 1654-1662, 2010 | 231 | 2010 |
| Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon … B Mlecnik, C Bifulco, G Bindea, F Marliot, A Lugli, JJ Lee, I Zlobec, TT Rau, ... Journal of clinical oncology 38 (31), 3638-3651, 2020 | 182 | 2020 |
| Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT R Lhommel, P Goffette, M Van den Eynde, F Jamar, S Pauwels, JI Bilbao, ... European journal of nuclear medicine and molecular imaging 36, 1696-1696, 2009 | 181 | 2009 |
| Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres P Flamen, B Vanderlinden, P Delatte, G Ghanem, L Ameye, ... Physics in Medicine & Biology 53 (22), 6591, 2008 | 175 | 2008 |
| Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial A Demols, I Borbath, M Van Den Eynde, G Houbiers, M Peeters, ... Annals of oncology 31 (9), 1169-1177, 2020 | 106 | 2020 |
| A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy C El Sissy, A Kirilovsky, M Van den Eynde, AM Muşină, MG Anitei, ... Clinical Cancer Research 26 (19), 5198-5207, 2020 | 99 | 2020 |
| An integrated tumor, immune and microbiome atlas of colon cancer J Roelands, PJK Kuppen, EI Ahmed, R Mall, T Masoodi, P Singh, ... Nature medicine 29 (5), 1273-1286, 2023 | 91 | 2023 |
| Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours? N Huyghe, P Baldin, M Van den Eynde Gastroenterology report 8 (1), 11-24, 2020 | 90 | 2020 |
| Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer F Marliot, X Chen, A Kirilovsky, T Sbarrato, C El Sissy, L Batista, ... Journal for immunotherapy of cancer 8 (1), e000272, 2020 | 73 | 2020 |
| Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab C Hubert, C Sempoux, Y Humblet, M van den Eynde, F Zech, I Leclercq, ... HPB 15 (11), 858-864, 2013 | 70 | 2013 |
| Chimeric antigen receptor-T cells for targeting solid tumors: current challenges and existing strategies L Springuel, C Lonez, B Alexandre, E Van Cutsem, JPH Machiels, ... BioDrugs 33, 515-537, 2019 | 62 | 2019 |
| Epidermal growth factor receptor targeted therapies for solid tumours M Van den Eynde, JF Baurain, F Mazzeo, JP Machiels Acta Clinica Belgica 66 (1), 10-17, 2011 | 59 | 2011 |
| HER2 as a predictive biomarker and treatment target in colorectal cancer A De Cuyper, M Van Den Eynde, JP Machiels Clinical colorectal cancer 19 (2), 65-72, 2020 | 54 | 2020 |
